Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-10

Clinical Trial Update: E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness [NA]

View source ↗

Summary

NYU Langone Health is recruiting participants for a clinical trial evaluating e-cigarettes as harm reduction among smokers with serious mental illness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Cigarette Smoking | NA | Status: RECRUITING